Table 4.
Comparison of post-CGMS glucose variation indexes of patients in three groups
| Variables | Insulinoma group (n = 44) | Hypoglycemia group (n = 26) | Control group (n = 31) | Chi square | P value |
|---|---|---|---|---|---|
| MBG* | 23.59 | 34.62 | 40.06 | 9.53 | 0.009 |
| SD* | 42.23 | 34.31 | 26.97 | 8.16 | 0.017 |
| CONGA* | 20.00 | 37.62 | 41.35 | 16.67 | 0.000 |
| LI* | 45.32 | 31.46 | 25.97 | 13.26 | 0.001 |
| J-Index | 29.59 | 36.38 | 35.06 | 1.41 | 0.494 |
| LBGI* | 49.68 | 31.38 | 22.90 | 25.24 | 0.000 |
| HBGI | 34.25 | 37.92 | 31.11 | 1.20 | 0.548 |
| GRADE* | 46.61 | 30.77 | 25.34 | 16.15 | 0.000 |
| MAGE* | 41.32 | 33.17 | 27.03 | 7.35 | 0.025 |
| M value* | 49.09 | 33.92 | 22.26 | 25.15 | 0.000 |
| MAG* | 49.36 | 34.85 | 21.68 | 26.85 | 0.000 |
MBG mean blood glucose, SD standard deviation, CONGA continuous overall net glycemic action, LI lability index, LBGI Low Blood Glucose Index, HBGI High Blood Glucose Index, GRADE glycaemic risk assessment diabetes equation, MAGE mean aplitude of glycaemic excursions, MAG mean absolute glucose
*P < 0.05